Get started
Author

Sofia Ioannou

Observed name: Ioannou, Sofia
ORCID: 0000-0003-4442-5783
Observed ORCID: 0000-0003-4442-5783
OpenAlex ID: A5039032133
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure
2022 · Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, et al. · Cell Reports Medicine · 34
PDF
Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
2023 · Job J. Engel, Caspar I. van der Made, et al. · Frontiers in Immunology · 33
PDF
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial
2022 · Karolina Akinosoglou, Antigone Kotsaki, et al. · EClinicalMedicine · 25
PDF
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial
2024 · Evdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, et al. · Critical Care · 21
PDF
A COVID-19 Patient with Simultaneous Renal Infarct, Splenic Infarct and Aortic Thrombosis during the Severe Disease
2022 · Georgios Mavraganis, Sofia Ioannou, et al. · Healthcare · 14
PDF
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host
2024 · Evdoxia Kyriazopoulou, Karolina Akinosoglou, et al. · International Journal of Antimicrobial Agents · 9
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial
2025 · Evdoxia Kyriazopoulou, Antigone Kotsaki, et al. · Intensive Care Medicine Experimental · 4
PDF
Health Promoting Properties of Vitamins C and D Against HIV Disease Progression, a Narrative Review
2024 · Garyfallos Markou, Ellie Panoutsopoulou, et al. · Immuno · 3
PDF
When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections?
2026 · Stelios F Assimakopoulos, Sofia Ioannou, et al. · JAC-Antimicrobial Resistance
Oral Lesions in People Living with HIV: The Lining HIV Study
2026 · Maria Gavatha, Emmanouil Angelos Rigopoulos, et al. · Pathogens
PDF
Early suPAR-Guided Anakinra Treatment in COVID-19 Pneumonia: Subgroup Analyses and 90-Day Outcomes of the SAVE-MORE Trial
2022 · Karolina Akinosoglou, Antigone Kotsaki, et al. · SSRN Electronic Journal
Works count: 14
Citation count: 143
H-index: 6
I10-index: 5
Year
Topic
Type